Tenon Medical, Inc.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

TNON$1.74-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Operations and Comprehensive Loss

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except per share data)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenue	$1,173	$887	$2,463	$2,507
Cost of sales	400	469	1,122	1,149
Gross Profit	773	418	1,341	1,358
Operating Expenses
Research and development	428	657	1,622	2,034
Sales and marketing	1,538	1,212	4,304	4,041
General and administrative	2,199	1,764	5,341	5,876
Total Operating Expenses	4,165	3,633	11,267	11,951
Loss from Operations	(3,392)	(3,215)	(9,926)	(10,593)
Other Income (Expense)
Gain on investments	53	31	202	97
Interest expense	—	—	—	(34)
Other expense, net	—	—	—	(56)
Total Other Income, net	53	31	202	7
Net Loss	$(3,339)	$(3,184)	$(9,724)	$(10,586)
Net Loss Per Share of Common Stock
Basic and diluted	$(0.40)	$(3.63)	$(1.48)	$(18.60)
Weighted-Average Shares of Common Stock Outstanding
Basic and diluted	8,250	877	6,581	569
Consolidated Statements of Comprehensive Loss:
Net loss	$(3,339)	$(3,184)	$(9,724)	$(10,586)
Foreign currency translation adjustment	—	—	—	46
Total comprehensive loss	$(3,339)	$(3,184)	$(9,724)	$(10,540)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.